Kamada (KMDA) Invested Capital (2016 - 2026)
Kamada (KMDA) posted quarterly Invested Capital of $10.6 million for Q1 2026, down 2.26% year-on-year from $10.9 million in Q1 2025, and up 7.26% on a QoQ basis from $9.9 million in Q4 2025.
Kamada (KMDA) Invested Capital (2016 - 2026) Analysis & Trends
Kamada (KMDA) has reported Invested Capital for 11 consecutive years, with $10.6 million the latest figure, recorded in Q1 2026.
- Quarterly Invested Capital fell 2.26% year-over-year to $10.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.0 million (down 5.0% YoY) and the FY2025 annual result came in at $9.9 million, down 2.53% from the prior year.
- Invested Capital climbed to $10.6 million in Q1 2026 per KMDA's latest filing, from $9.9 million in the prior quarter.
- Over the last five years, Invested Capital for KMDA reached as high as $105.2 million in Q4 2022 and fell as low as $25095.0 in Q3 2022.
- A 5-year average of $17.5 million and a median of $10.9 million in 2025 frame the typical range for Invested Capital.
- The largest YoY upside for Invested Capital was 63613.89% in 2023 against a maximum downside of 99.85% in 2023.
- Year by year, Invested Capital stood at $105.2 million in 2022, then plunged by 85.74% to $15.0 million in 2023, then plunged by 32.11% to $10.2 million in 2024, then declined by 2.53% to $9.9 million in 2025, then rose by 7.26% to $10.6 million in 2026.
- According to Business Quant data, Invested Capital over the past three periods registered $10.6 million, $9.9 million, and $10.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 10.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.64 Mn |
| Dec 31, 2025 | 9.92 Mn |
| Sep 30, 2025 | 10.59 Mn |
| Jun 30, 2025 | 9.85 Mn |
| Mar 31, 2025 | 10.89 Mn |
| Dec 31, 2024 | 10.18 Mn |
| Sep 30, 2024 | 9.48 Mn |
| Jun 30, 2024 | 12.61 Mn |
| Mar 31, 2024 | 12.98 Mn |
| Dec 31, 2023 | 15.00 Mn |
| Sep 30, 2023 | 15.99 Mn |
| Jun 30, 2023 | 25.08 Mn |
| Mar 31, 2023 | 29,414.00 |
| Dec 31, 2022 | 105.15 Mn |
| Sep 30, 2022 | 25,095.00 |
| Jun 30, 2022 | 20.12 Mn |
| Mar 31, 2022 | 19.10 Mn |
| Dec 31, 2021 | 3.79 Mn |
| Sep 30, 2021 | 52,000.00 |
| Jun 30, 2021 | 61,000.00 |